January 22-24, 2020
Hyatt Regency Coral Gables ● Coral Gables, FL

Navigate Regulatory Changes, Develop Strategies for Sharing Patient Data and Elevate Medical Writing

The clinical data transparency landscape is shifting as U.S. and global regulations are continuing to evolve. Gain insight from an expert speaking faculty, prepare yourself and your team by hearing regulatory perspectives & keynotes, and gain a laser focus on data sharing.

Key Insights and Takeaways:

Gain Insight on Stakeholder Perspectives of Clinical Data and Data Sharing

Nate Root
Associate Director, Clinical Disclosure and Transparency, Ionis Pharmaceuticals

Liz Roberts
Global Public Policy Lead, External Engagement Practice, UCB

Kelly Coulbourne
Associate Director, Clinical Trial Data Registries, Allergan

Laser Focus on Data Sharing

Global Disclosure Mandates
Plain Language Summaries
Data & Document Anonymization
Medical & Regulatory Writing Strategies
Strategic Communication of Clinical Trial Results

Regulatory Perspectives & Keynotes

Focused on evolving regulations and initiatives from the EMA and FDA
Prepare your organization for Health Canada Implementation
Explore global regulations and guidance’s effect on disclosure and transparency

3 IN-DEPTH TRACKS…

Paper DH10

Managing Privacy Risk in Data and Document Sharing: Lessons Learned Balancing Progress & Perfection

Read the opinions of Julie Holtzople (Astrazeneca) and Jean-Marc Ferran (Qualiance) as they discuss balancing progress against perfection in clinical trial disclosure.

This whitepaper dives into fundamental questions that organizations often ask when sharing their internal process based on balancing utility and privacy. To learn more, download the whitepaper.

Download Whitepaper

Connect with Key Decision-Makers at Clinical Data Disclosure, Transparency & Plain Language Summaries

Whether you’re looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.

For more information about custom opportunities to reach a qualified audience, contact LifeSciencePartners@informaconnectls.com.

DOWNLOAD SPONSOR PROSPECTUS

Director, Medical Communications

Duke Clinical Research Institute

Really great conference focused on the nuances and challenges in the niche field of Clinical data transparency. It is helping move the cause of data sharing by pulling in all key stakeholders to the table for engaging conversation.

Navigate Regulatory Changes, Develop Strategies for Sharing Patient Data and Elevate Medical Writing

The clinical data transparency landscape is shifting as U.S. and global regulations are continuing to evolve. Gain insight from an expert speaking faculty, prepare yourself and your team by hearing regulatory perspectives & keynotes, and gain a laser focus on data sharing.

Key Insights and Takeaways:

Gain Insight on Stakeholder Perspectives of Clinical Data and Data Sharing

Gain Insight on Stakeholder Perspectives of Clinical Data and Data Sharing

Laser Focus on Data Sharing

Laser Focus on Data Sharing

Regulatory Perspectives & Keynotes

Regulatory Perspectives & Keynotes

3 IN-DEPTH TRACKS…

Clinical Disclosure & Anonymization

Clinical Disclosure & Anonymization

Plain Language Summaries & Dissemination Strategies

Plain Language Summaries & Dissemination Strategies

Regulatory & Medical Writing

Regulatory & Medical Writing

Paper DH10

Managing Privacy Risk in Data and Document Sharing: Lessons Learned Balancing Progress & Perfection

Connect with Key Decision-Makers at Clinical Data Disclosure, Transparency & Plain Language Summaries

The CBI conference was a great value. Excellent speakers and discussion provided a 360-degree view of each issue. It is such a pleasure to be in the disclosure community where we share knowledge and ideas with peers – as well as the key opinion leaders of tomorrow.

CBI's transparency programs are second to none when it comes to the quality of presentations!

Really great conference focused on the nuances and challenges in the niche field of Clinical data transparency. It is helping move the cause of data sharing by pulling in all key stakeholders to the table for engaging conversation.

Getting updated on guidelines and learning real-life solutions from lively conversations and networking in a smaller venue that allows for more interactions.

A great way to learn about the challenges being faced by other companies and proposed solutions.

The CBI conference was a great value. Excellent speakers and discussion provided a 360-degree view of each issue. It is such a pleasure to be in the disclosure community where we share knowledge and ideas with peers – as well as the key opinion leaders of tomorrow.

CBI's transparency programs are second to none when it comes to the quality of presentations!

Really great conference focused on the nuances and challenges in the niche field of Clinical data transparency. It is helping move the cause of data sharing by pulling in all key stakeholders to the table for engaging conversation.

Getting updated on guidelines and learning real-life solutions from lively conversations and networking in a smaller venue that allows for more interactions.

A great way to learn about the challenges being faced by other companies and proposed solutions.

The CBI conference was a great value. Excellent speakers and discussion provided a 360-degree view of each issue. It is such a pleasure to be in the disclosure community where we share knowledge and ideas with peers – as well as the key opinion leaders of tomorrow.

CBI's transparency programs are second to none when it comes to the quality of presentations!